Table 1.
Insulin | Onset of action | Peak | Duration |
---|---|---|---|
Rapid acting (analog) | |||
aspart | 10–20 minutes | 1–3 hours | 3–5 hours |
lispro | 15–30 minutes | 0.5–2.5 hours | 3–6.5 hours |
glulisine | 10–15 minutes | 1–1.5 hours | 3–5 hours |
Short-acting (human) | |||
Regular | 30–60 minutes | 1–5 hours | 6–10 hours |
Intermediate (human) | |||
NPH | 1–2 hours | 6–14 hours | 16–24+ hours |
Long-acting (analog) | |||
detemir | 0.8–2 hours | No significant peak | Up to 24 hours |
glargine | 1.1 hours | No significant peak | Up to 24 hours |
Premixed (analog) | |||
70% APS/30% aspart | 10–20 minutes | 1–4 (2.4) hours† | Up to 24 hours |
75% NPL/25% lispro | 10–30 minutes | 1–6.5 (2.6) hours† | Up to 24 hours |
50% NPL/50% lispro | 10–30 minutes | 0.8–4.8 (2.3) hours† | Up to 24 hours |
Premixed (human) | |||
70% NPH/30% regular | 30–60 minutes | 1.5–16 (4.4) hours† | Up to 18–24 hours |
50% NPH/50% regular | 30–60 minutes | 2–5.5 (3.3) hours† | Up to 18–24 hours |
Range (mean)
NPH = neutral protamine Hagedorn; APS = aspart protamine suspension; NPL = neutral protamine lispro
Adapted with permission from Allen.[4]